Slide 1: Investor Presentation Q3 & 9M FY2022
INVESTOR PRESENTATION Q3 & 9M FY2022 Refer to disclaimer Q3 & 9M FY22 - Investor presentation 1
Slide 2: Disclaimer
Disclaimer This document has been prepared for information purposes only and is not an offer or invitation or recommendation to buy or sell any securities of Control Print Limited (“CPL”, "Company“), nor shall part, or all, of this document form the basis of, or be relied on in connection with, any
Slide 3: Contents
Contents Quarterly Company Key notes Performance Overview Highlights Annual Way Performance Forward Highlights Q3 & 9M FY22 - Investor presentation 3
Slide 4: Company Overview
Company Overview Control Print has over 30 years of operational experience in the Indian coding and marking industry. With over 360 field staff and two state of the art factories, we are India's strongest and most reliable partner to you our customers. Our representatives tailor their purchase advic
Slide 5: Products
Products Continuous InkJet High Hot Roll Large Character Printer Resolution Printer Coder Printer Thermal Inkjet Thermal Transfer Laser Printer Consumables Printer Overprinter Q3 & 9M FY22 - Investor presentation 5
Slide 6: Industries We Serve
Industries We Serve Agrochemicals and Seeds Food Automotive Healthcare Beverages Packaging and Packaging Materials Building and Construction Plywood Materials Cable and Wire Pipes and Extruded Plastics Cement Rubber and Tyres Chemicals and Lubricants Steel and Metal Electronics Textiles FMCG Q3 & 9M
Slide 7: Key clients: India
Key clients: India Q3 & 9M FY22 - Investor presentation
Slide 8: Infrastructure
Infrastructure NALAGARH FACTORY GUWAHATI FACTORY 30,000 Sq.ft manufacturing facility 70,000 sq.ft of manufacturing & warehousing facility Manufacturing of: Ink & Solvent manufacturing facility • Continuous Inkjet Printer (CIJ) Manufacturing of: • Large Character Printer (LCP) • Thermal Ink
Slide 9: Key Notes
KEY NOTES Q3 & 9M FY22 - Investor presentation 9
Slide 10: Key Notes
Key Notes Crisil re-affirms Installed base of credit rating printer crosses at ‘A’ 14,000 mark Only integrated Surgical Mask received “Make in India” US FDA approval – 4 th manufacturer company in India to get this accreditation Q3 & 9M FY22 - Investor presentation 10
Slide 11: Our Investor Value Proposition
Our Investor Value Proposition The only integrated player with full Your Gateway to participate in the fastest The only “Make in India” company in the Underpenetrated segment, hence coverage of coding and marking value growing and highly niche coding and Top four players in India commanding headroom
Slide 12: Quarter Performance Highlights
QUARTER PERFORMANCE HIGHLIGHTS Q3 & 9M FY22 - Investor presentation 12
Slide 13: Key highlights for the quarter
Key highlights for the quarter Revenue Growth Positives Quarterly run rate of Rs.600+ mn Working Capital witnessed revenue maintained. improvement by 32 days for 9MFY22 led by better inventory management Strongest ever performance for Q3. and receivable recovery. Revenue growth of 25.3% for 9MFY22 P
Slide 14: Brief Financials for the quarter
Brief Financials for the quarter Particulars (Rs mn) Q3FY22 Q2FY22 Q3FY21 YoY (%) 9MFY22 9MFY21 YoY (%) Net sales 615.8 627.2 546.4 12.7 1,786.9 1,426.1 25.3 Gross Profit 373.2 379.6 328.0 13.8 1,088.6 892.6 22.0 Gross margin (%) 60.61 60.52 60.03 +58 bps 60.92 62.59 -167 bps EBITDA 147.9 159.0 131.
Slide 15: Synopsis of Quarterly Performance (1/2)
Synopsis of Quarterly Performance (1/2) Highest ever revenue for Q3 400 75.0 640 611 627 616 350 560 530 546 544 70.0 300 474 462 480 Rs. in Mn 250 67.6 65.0 Rs. in Mn 400 349 (%) 200 63.5 320 60.1 61.7 150 60.5 60.6 60.0 240 59.9 58.8 58.7 160 100 55.0 80 50 0 0 50.0 Q3 FY20 Q4 FY20 Q1 FY21 Q2FY21
Slide 16: Synopsis of Quarterly Performance (2/2)
Synopsis of Quarterly Performance (2/2) EBITDA maintained above 24% 180 35% 159 160 152 148 30% 28.1% 140 133 130 131 130 24.3% 24.9% 25.4% 24.5% 24.0% 24.0% 118 122 25% 120 113 21.7% 110 18.4% 20% 23.3% Rs. in Mn 100 93 96 21.4% 85 85 87 19.4% 18.4% 17.6% 18.4% 80 15% 17.4% 65 64 16.0% 14.1% 60 10%
Slide 17: Annual Performance Highlights
ANNUAL PERFORMANCE HIGHLIGHTS Q3 & 9M FY22 - Investor presentation 17
Slide 18: Annual Profit & Loss Statement
Annual Profit & Loss Statement Particulars (Rs mn) FY17 FY18 FY19 FY20 FY21 Net sales 1,473.5 1,739.3 1,746.0 1,949.2 2036.9 Gross Profit 953.2 1186.3 1132.0 1218.5 1251.0 Gross margin (%) 64.70 68.21 64.84 62.51 61.42 EBITDA 382.6 501.6 399.8 461.0 498.2 EBITDA margin (%) 25.96 28.84 22.90 23.65 24
Slide 19: Synopsis of Annual Performance (1/2)
Synopsis of Annual Performance (1/2) Revenue (Rs mn) 2,500 80.0 70.0 68.2 66.3 64.7 64.8 2,036.9 62.5 2,000 1,949.2 61.42 1,746.0 60.0 1,739.4 1,473.5 50.0 1,500 Gross Margins maintained above 60% 1,345.2 EBITDA Margin maintained above 24% (%) 40.0 1,000 27.8 30.0 25.8 25.3 25.0 23.6 24.46 20.0 500
Slide 20: Synopsis of Annual Performance (2/2)
Synopsis of Annual Performance (2/2) 30.0 30.0 28.0 28.0 26.0 25.0 Mid to high teen PAT 26.0 Low tax rate led by Guwahati 24.5 margins maintained 23.3 operations tax benefits 24.0 24.0 22.2 22.0 21.4 21.4 22.0 20.3 20.0 19.2 20.0 18.2 18.5 18.0 19.2 18.0 17.2 16.7 16.0 17.4 17.1 16.0 16.8 15.9 15.3
Slide 21: Way Forward
WAY FORWARD Q3 & 9M FY22 - Investor presentation 21
Slide 22: Way Forward
Way Forward Higher Newly Replacement Focused Larger Market Consumables Launched Market, OEM marketing plans Share with Mask Division Sales with products to and Key to capture last increasing contributes in improved deliver Accounts to be mile user. installed base FY21-22 industrial exponential the d
Slide 23: Thank You
THANK YOU For further information please contact Rahul Khettry KAPTIFY® Chief Financial Officer Strategy & Investor Advisory | Consulting Email: cfo@controlprint.com Email: contact@kaptify.in | +91-845 288 6099 Website: www.controlprint.com Website: www.kaptify.in Q3 & 9M FY22 - Investor presentatio